Quang VT, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, Freynet N, Parinet V, Leclerc M, Maury S, Solary E, Selimoglu-Buet D, Duployez N, Wagner-Ballon O, Sloma I. <i>TET2</i&gt; mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia. Haematologica 2023;108(11):3135-3141; https://doi.org/10.3324/haematol.2022.282528.